DOSAGE REGIMEN OF VIDOFLUDIMUS FOR USE IN THE PREVENTION OR TREATMENT OF CHRONIC INFLAMMATORY AND/OR AUTOIMMUNE DISEASES

DOSAGE REGIMEN OF VIDOFLUDIMUS FOR USE IN THE PREVENTION OR TREATMENT OF CHRONIC INFLAMMATORY AND/OR AUTOIMMUNE DISEASES

The present invention refers to a 2-({3-fluoro-3'-methoxy-[1,1'-biphenyl]-4- yl}carbamoyl)cyclopent-1-ene-1-carboxylic acid) according to formula (I) and a novel dosage regimen as well as their uses in the treatment of chronic inflammatory and/or autoimmune diseases. The said compound of f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KOHLHOF, HELLA, VITT, DANIEL, GROPPEL, MANFRED, MUHLER, ANDREAS
Format: Patent
Sprache:eng ; fre
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KOHLHOF, HELLA
VITT, DANIEL
GROPPEL, MANFRED
MUHLER, ANDREAS
description The present invention refers to a 2-({3-fluoro-3'-methoxy-[1,1'-biphenyl]-4- yl}carbamoyl)cyclopent-1-ene-1-carboxylic acid) according to formula (I) and a novel dosage regimen as well as their uses in the treatment of chronic inflammatory and/or autoimmune diseases. The said compound of formula (I) inhibits dihydroorotate dehydrogenase (DHODH), and is known for the treatment and prevention of diseases, in particular their use in diseases where there is an advantage in inhibiting dihydroorotate dehydrogenase (DHODH). La présente invention concerne un 2-({3-fluoro-3'-methoxy-[1,1'-biphényl]-4- yl}carbamoyl)cyclopent-1-ène-1-acide carboxylique) selon la formule (I) et une nouvelle posologie, ainsi que leurs utilisations dans le traitement de maladies inflammatoires chroniques et/ou auto-immunes. Ledit composé de formule (I) inhibe la dihydroorotate déshydrogénase (DHODH), et est connu pour le traitement et la prévention de maladies, en particulier son utilisation dans des maladies où il est bénéfique d'inhiber la dihydroorotate déshydrogénase (DHODH).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3083155A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3083155A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3083155A13</originalsourceid><addsrcrecordid>eNqNy7EKwjAQgOEuDqK-w72AaCkF1yO5tIEmJ8ml4FSKxEm0UAcf3wo-gNO_fP-6eGuO2BAEaqwjD2ygt5pNl7R1KYLhACkSWA_SEpwD9eTF8iIDSCCU5ZLvptrA3qpFmg6dQ-FwAfT6sEBMwta55Am0jYSR4rZY3cb7nHe_bgowJKrd5-k55Hkar_mRX4PC6niqyrrGsvqDfAApLzmS</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DOSAGE REGIMEN OF VIDOFLUDIMUS FOR USE IN THE PREVENTION OR TREATMENT OF CHRONIC INFLAMMATORY AND/OR AUTOIMMUNE DISEASES</title><source>esp@cenet</source><creator>KOHLHOF, HELLA ; VITT, DANIEL ; GROPPEL, MANFRED ; MUHLER, ANDREAS</creator><creatorcontrib>KOHLHOF, HELLA ; VITT, DANIEL ; GROPPEL, MANFRED ; MUHLER, ANDREAS</creatorcontrib><description>The present invention refers to a 2-({3-fluoro-3'-methoxy-[1,1'-biphenyl]-4- yl}carbamoyl)cyclopent-1-ene-1-carboxylic acid) according to formula (I) and a novel dosage regimen as well as their uses in the treatment of chronic inflammatory and/or autoimmune diseases. The said compound of formula (I) inhibits dihydroorotate dehydrogenase (DHODH), and is known for the treatment and prevention of diseases, in particular their use in diseases where there is an advantage in inhibiting dihydroorotate dehydrogenase (DHODH). La présente invention concerne un 2-({3-fluoro-3'-methoxy-[1,1'-biphényl]-4- yl}carbamoyl)cyclopent-1-ène-1-acide carboxylique) selon la formule (I) et une nouvelle posologie, ainsi que leurs utilisations dans le traitement de maladies inflammatoires chroniques et/ou auto-immunes. Ledit composé de formule (I) inhibe la dihydroorotate déshydrogénase (DHODH), et est connu pour le traitement et la prévention de maladies, en particulier son utilisation dans des maladies où il est bénéfique d'inhiber la dihydroorotate déshydrogénase (DHODH).</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190531&amp;DB=EPODOC&amp;CC=CA&amp;NR=3083155A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190531&amp;DB=EPODOC&amp;CC=CA&amp;NR=3083155A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KOHLHOF, HELLA</creatorcontrib><creatorcontrib>VITT, DANIEL</creatorcontrib><creatorcontrib>GROPPEL, MANFRED</creatorcontrib><creatorcontrib>MUHLER, ANDREAS</creatorcontrib><title>DOSAGE REGIMEN OF VIDOFLUDIMUS FOR USE IN THE PREVENTION OR TREATMENT OF CHRONIC INFLAMMATORY AND/OR AUTOIMMUNE DISEASES</title><description>The present invention refers to a 2-({3-fluoro-3'-methoxy-[1,1'-biphenyl]-4- yl}carbamoyl)cyclopent-1-ene-1-carboxylic acid) according to formula (I) and a novel dosage regimen as well as their uses in the treatment of chronic inflammatory and/or autoimmune diseases. The said compound of formula (I) inhibits dihydroorotate dehydrogenase (DHODH), and is known for the treatment and prevention of diseases, in particular their use in diseases where there is an advantage in inhibiting dihydroorotate dehydrogenase (DHODH). La présente invention concerne un 2-({3-fluoro-3'-methoxy-[1,1'-biphényl]-4- yl}carbamoyl)cyclopent-1-ène-1-acide carboxylique) selon la formule (I) et une nouvelle posologie, ainsi que leurs utilisations dans le traitement de maladies inflammatoires chroniques et/ou auto-immunes. Ledit composé de formule (I) inhibe la dihydroorotate déshydrogénase (DHODH), et est connu pour le traitement et la prévention de maladies, en particulier son utilisation dans des maladies où il est bénéfique d'inhiber la dihydroorotate déshydrogénase (DHODH).</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNy7EKwjAQgOEuDqK-w72AaCkF1yO5tIEmJ8ml4FSKxEm0UAcf3wo-gNO_fP-6eGuO2BAEaqwjD2ygt5pNl7R1KYLhACkSWA_SEpwD9eTF8iIDSCCU5ZLvptrA3qpFmg6dQ-FwAfT6sEBMwta55Am0jYSR4rZY3cb7nHe_bgowJKrd5-k55Hkar_mRX4PC6niqyrrGsvqDfAApLzmS</recordid><startdate>20190531</startdate><enddate>20190531</enddate><creator>KOHLHOF, HELLA</creator><creator>VITT, DANIEL</creator><creator>GROPPEL, MANFRED</creator><creator>MUHLER, ANDREAS</creator><scope>EVB</scope></search><sort><creationdate>20190531</creationdate><title>DOSAGE REGIMEN OF VIDOFLUDIMUS FOR USE IN THE PREVENTION OR TREATMENT OF CHRONIC INFLAMMATORY AND/OR AUTOIMMUNE DISEASES</title><author>KOHLHOF, HELLA ; VITT, DANIEL ; GROPPEL, MANFRED ; MUHLER, ANDREAS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3083155A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2019</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KOHLHOF, HELLA</creatorcontrib><creatorcontrib>VITT, DANIEL</creatorcontrib><creatorcontrib>GROPPEL, MANFRED</creatorcontrib><creatorcontrib>MUHLER, ANDREAS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KOHLHOF, HELLA</au><au>VITT, DANIEL</au><au>GROPPEL, MANFRED</au><au>MUHLER, ANDREAS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DOSAGE REGIMEN OF VIDOFLUDIMUS FOR USE IN THE PREVENTION OR TREATMENT OF CHRONIC INFLAMMATORY AND/OR AUTOIMMUNE DISEASES</title><date>2019-05-31</date><risdate>2019</risdate><abstract>The present invention refers to a 2-({3-fluoro-3'-methoxy-[1,1'-biphenyl]-4- yl}carbamoyl)cyclopent-1-ene-1-carboxylic acid) according to formula (I) and a novel dosage regimen as well as their uses in the treatment of chronic inflammatory and/or autoimmune diseases. The said compound of formula (I) inhibits dihydroorotate dehydrogenase (DHODH), and is known for the treatment and prevention of diseases, in particular their use in diseases where there is an advantage in inhibiting dihydroorotate dehydrogenase (DHODH). La présente invention concerne un 2-({3-fluoro-3'-methoxy-[1,1'-biphényl]-4- yl}carbamoyl)cyclopent-1-ène-1-acide carboxylique) selon la formule (I) et une nouvelle posologie, ainsi que leurs utilisations dans le traitement de maladies inflammatoires chroniques et/ou auto-immunes. Ledit composé de formule (I) inhibe la dihydroorotate déshydrogénase (DHODH), et est connu pour le traitement et la prévention de maladies, en particulier son utilisation dans des maladies où il est bénéfique d'inhiber la dihydroorotate déshydrogénase (DHODH).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA3083155A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title DOSAGE REGIMEN OF VIDOFLUDIMUS FOR USE IN THE PREVENTION OR TREATMENT OF CHRONIC INFLAMMATORY AND/OR AUTOIMMUNE DISEASES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T20%3A53%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KOHLHOF,%20HELLA&rft.date=2019-05-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3083155A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true